Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
8.53
0.01 (0.12%)
At close: Aug 21, 2025, 12:39 PM
Y-mAbs Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 62.29M | 60.31M | 67.23M | 68.12M | 77.81M | 75.75M | 78.64M | 86.57M | 87.91M | 92.63M | 105.76M | 114.53M | 133.66M | 156.72M | 181.56M | 215.73M | 233.59M | 252.27M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 19.87M | 19.19M | 18.26M | 18.37M | 13.46M | 11.17M | 12.49M | 9.41M | 12.25M | 8.66M | 5.68M | 5.6M | 5.75M | 6.84M | 3.17M | 2.95M | 2.99M | 3.03M |
Receivables | 15.74M | 17.74M | 19.69M | 19.92M | 38.22M | 20.59M | 22.45M | 18.87M | 19.12M | 18.7M | 12.53M | 9.25M | 7.21M | 9.32M | 7.71M | 7.26M | 8.52M | 6M |
Inventory | 9.72M | 8M | 7.21M | 9.56M | 8.5M | 8.45M | 5.07M | 7.11M | 5.19M | 8.95M | 6.7M | 6.24M | 6.79M | 5.59M | 5.51M | 4.79M | 3.82M | 1M |
Other Current Assets | 4.04M | 4.4M | 4.37M | 1.46M | 2.24M | 3.48M | 4.96M | 2.3M | 3.57M | 3.73M | 5.45M | 3.23M | 6.25M | 6.1M | 7.47M | 2.8M | 3.44M | 4.74M |
Total Current Assets | 91.79M | 90.45M | 98.51M | 99.06M | 126.76M | 108.27M | 111.11M | 114.86M | 115.78M | 124.01M | 130.45M | 133.24M | 153.92M | 177.74M | 202.26M | 230.58M | 249.37M | 264.01M |
Property-Plant & Equipment | 3.38M | 762K | 859K | 1.13M | 1.36M | 1.33M | 1.64M | 1.89M | 1.55M | 1.88M | 2.34M | 3.54M | 3.94M | 4.85M | 5.69M | 4.65M | 5.32M | 6.07M |
Goodwill & Intangibles | 2.18M | 2.21M | 2.28M | 2.37M | 2.45M | 2.54M | 2.63M | 2.72M | 2.81M | 2.9M | 2.99M | 1.53M | 1.57M | 1.62M | 1.66M | 1.8M | 1.8M | 1.8M |
Total Long-Term Assets | 25.42M | 22.16M | 21.39M | 21.86M | 17.27M | 15.05M | 16.76M | 14.02M | 16.61M | 13.44M | 11.01M | 10.67M | 11.26M | 13.31M | 10.52M | 9.4M | 10.11M | 10.91M |
Total Assets | 117.21M | 112.61M | 119.9M | 120.92M | 144.03M | 123.31M | 127.87M | 128.88M | 132.4M | 137.44M | 141.46M | 143.91M | 165.18M | 191.05M | 212.78M | 239.98M | 259.48M | 274.92M |
Account Payables | 7.57M | 4.63M | 6.66M | 7.88M | 10.19M | 6.73M | 6.06M | 7.61M | 7.25M | 8.84M | 14.18M | 13.72M | 11.29M | 14.66M | 13.55M | 11.02M | 6.8M | 6.54M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 486K | n/a | n/a | n/a | n/a | 888K | 902K | 898K | 829K | 855K | n/a | 1.2M | 1.09M | 1.45M | n/a | 1.85M | n/a | 1.97M |
Other Current Liabilities | 11.3M | 3.29M | 16.41M | 16.64M | 25.85M | 1.28M | 8.41M | 9.6M | 12.81M | 11.23M | 2.44M | 11.82M | 11.82M | 9.36M | 5.71M | 6.59M | 4.49M | 3.52M |
Total Current Liabilities | 22.95M | 18.96M | 23.7M | 25.29M | 43.47M | 17.61M | 20.13M | 21.81M | 24.23M | 25.92M | 28.28M | 32.02M | 29.45M | 29.04M | 27.88M | 25.36M | 20.99M | 17M |
Long-Term Debt | 2.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 4.13M | 4.05M | 4.01M | 2.9M | 4.8M | 6.23M | 6.24M | 6.2M | 3.07M | 3.07M | 3.05M | 2.98M | 3.03M | 2.94M | 2.95M | 3.12M | 3.19M | 4.18M |
Total Long-Term Liabilities | 6.77M | 4.2M | 4.2M | 3.2M | 5.23M | 6.52M | 6.76M | 6.92M | 3.48M | 3.7M | 3.95M | 4M | 4.33M | 4.53M | 4.8M | 3.77M | 4.18M | 5.7M |
Total Liabilities | 29.72M | 23.16M | 27.9M | 28.49M | 48.7M | 24.13M | 26.88M | 28.73M | 27.71M | 29.62M | 32.23M | 36.02M | 33.78M | 33.58M | 32.68M | 29.13M | 25.16M | 22.7M |
Total Debt | 3.12M | 603K | 820K | 1.07M | 1.27M | 1.18M | 1.42M | 1.62M | 1.25M | 1.48M | 1.77M | 2.22M | 2.39M | 3.05M | 3.63M | 2.5M | 3M | 3.49M |
Common Stock | 5K | 5K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -495.57M | -492.33M | -487.14M | -480.35M | -473.35M | -464.1M | -457.47M | -456.48M | -448.74M | -442.43M | -436.04M | -437.2M | -409.67M | -368.54M | -340.48M | -303.58M | -274.72M | -251.79M |
Comprehensive Income | -612K | 1.4M | 2.26M | -36K | 1.05M | 848K | 449K | 1.85M | 1.04M | 1.02M | 1.33M | 4.7M | 3.1M | 1.68M | 1.37M | 225K | -13K | -91K |
Shareholders Equity | 87.49M | 89.46M | 92M | 92.43M | 95.34M | 99.19M | 100.98M | 100.15M | 104.68M | 107.83M | 109.22M | 107.9M | 131.4M | 157.47M | 180.11M | 210.84M | 234.32M | 252.22M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |